Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc V.VIV.H

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV.H - Post by User

Avivagen Inc > FARMER HERE
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Comment by DrJayseron Aug 26, 2020 2:16pm
91 Views
Post# 31456774

RE:RE:RE:RE:RE:RE:FARMER HERE

RE:RE:RE:RE:RE:RE:FARMER HERECeo was paid 412,000$ in F19, owns 266,000 shares !

I wonder if StoneHead has more shares than him?

Avivagen has a truly disruptive  compensation committee.

Groome the ex-CEO was paid 255,000$ in 2016, somehow same job in 2019 is worth 62% more!

Material uncertainty related to going concern We draw attention to Note 1 in the financial statements, which indicates that the Company incurred a loss during the year ended October 31, 2019 and had a cumulative deficit as at October 31, 2019. As stated in Note 1, these events or conditions, along with other matters as set forth in Note 1, indicate that material uncertainties exist that cast significant doubt on the Company’s ability to continue as a going concern. Our opinion is not modified in respect of this matter....

It did loose $4.8M in 2019 and 2018 also.

Gross Margins on sales were 525,000$CAD  in 2019 compared to $653,000 CAD in 2018. 

Great Job Team



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities